Neurogene Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 28.82 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 576.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
Details
| Name | Neurogene Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 131 |
| Founded | 2003 |
| Ceo | Rachel McMinn |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US64135M1053 |
| Cusip | 64135M105 |
| Cik | 1404644 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Rachel L. McMinn Ph.D. | Founder, Executive Chair and Chief Executive Officer |
| Christine Mikail Cvijic J.D. | President, Chief Financial Officer and Director |
| Dr. Julie Jordan M.D. | Chief Medical Officer |
| Dr. Stuart Cobb Ph.D. | Chief Scientific Officer |
| Lina Li | Executive Director of Investor Relations |
| Donna M. Cochener-Metcalfe J.D., L.L.M. | Senior Vice President, General Counsel and Corporate Secretary |
| Dr. Andrew E. Mulberg CPI, FAAP, M.D. | Senior Vice President of Regulatory Affairs, Quality Assurance and Quality Control |
| Ricardo Jimenez | Senior Vice President of Technical Operations |
| Arvind Sreedharan | Senior Vice President of Business Operations |
| Christina Shafer | Chief Commercial Officer |
Contact
| Address | 535 W 24th Street, 5th Floor, New York, New York 10011, United States |
| Phone | 855 508 3568 |
| Website | https://www.neurogene.com |